Skip to main content

Amgen balance sheet

  • AMGN · Nasdaq
  • Biotechnology
  • S&P 500
$465.67−0.30%Close 13 Nov 2026 · Market value $253.3B

At the end of fiscal 2025 (the year to 31 Dec 2025), Amgen reported total assets of $90.59B, $9.13B in cash and equivalents, $55.44B of total debt; shareholders' equity was $8.66B.

From Amgen's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Amgen balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$2.02B$1.77B$2.88B$3.29B$6.95B$3.26B$3.81B$3.73B$4.14B$3.24B$3.80B$6.95B$6.04B$6.27B$7.99B$7.63B$10.94B$11.97B$9.13B
Short-term investments—$7.78B$10.56B$14.13B$13.70B$20.80B$15.60B$23.30B$27.24B$34.84B$37.88B$22.36B$2.87B$4.38B$48.00M$1.68B$0.00——
Cash and short-term investments$2.02B$9.55B$13.44B$17.42B$20.64B$24.06B$19.40B$27.03B$31.38B$38.09B$41.68B$29.30B$8.91B$10.65B$8.04B$9.30B$10.94B$11.97B$9.13B
Accounts receivable—$2.07B$2.11B$2.33B$2.90B$2.52B$2.70B$2.55B$3.00B$3.17B$3.24B$3.58B$4.06B$4.53B$4.89B$5.56B$7.27B$6.78B$9.57B
Inventory—$2.08B$2.22B$2.02B$2.48B$2.74B$3.02B$2.65B$2.44B$2.75B$2.83B$2.94B$3.58B$3.89B$4.09B$4.93B$9.52B$7.00B$6.22B
Current assets—$15.22B$18.93B$23.13B$27.59B$31.21B$27.37B$34.71B$38.52B$46.01B$49.48B$37.62B$18.44B$21.14B$19.39B$22.19B$30.33B$29.03B$29.06B
Property, plant and equipment—$5.88B$5.74B$5.52B$5.42B$5.33B$5.35B$5.22B$4.91B$4.96B$4.99B$4.96B$4.93B$4.89B$5.18B$5.43B$5.94B$6.54B$7.91B
Goodwill—$11.34B$11.34B$11.33B$11.75B$12.66B$14.97B$14.79B$14.79B$14.75B$14.76B$14.70B$14.70B$14.69B$14.89B$15.53B$18.63B$18.64B$18.68B
Acquired intangibles—$2.99B$2.57B$2.23B$2.58B$3.97B$13.26B$12.69B$11.64B$10.28B$8.61B$7.44B$19.41B$16.59B$15.18B$16.08B$32.64B$27.70B$22.28B
Total assets—$36.43B$39.63B$43.49B$48.87B$54.30B$66.13B$69.01B$71.45B$77.63B$79.95B$66.42B$59.71B$62.95B$61.16B$65.12B$97.15B$91.84B$90.59B
Accounts payable—$504.0M$574.0M$716.0M$642.0M$905.0M$787.0M$995.0M$965.0M$917.0M$1.35B$1.21B$1.37B$1.42B$1.37B$1.57B$1.59B$1.91B$2.37B
Short-term borrowings———$0.00—————$0.00————$0.00$0.00$0.00$0.00$0.00
Long-term debt · current portion—$1.00B$0.00$2.49B$84.00M$2.50B$2.50B$500.0M$2.25B$4.40B$1.15B$4.42B$2.95B$91.00M$87.00M$1.59B$1.44B$3.55B$4.60B
Current liabilities—$4.89B$3.87B$6.57B$5.75B$8.19B$7.95B$7.01B$8.66B$11.20B$9.02B$13.49B$12.84B$11.65B$12.18B$15.69B$18.39B$23.10B$25.49B
Long-term debt · non-current—$4.26B$10.60B$10.87B——$29.62B$30.21B$29.18B$30.19B$34.19B$29.51B$26.95B$32.90B$33.22B$37.35B$63.17B$56.55B$50.01B
Operating lease liability————————————$528.0M$459.0M$670.0M$695.0M$810.0M$780.0M$831.0M
Total liabilities—$15.54B$16.96B$19.54B$29.84B$35.24B$44.03B$43.23B$43.37B$47.75B$54.71B$53.92B$50.03B$53.54B$54.47B$61.46B$90.92B$85.96B$81.93B
Retained earnings—−$5.67B−$4.32B−$3.51B−$8.92B−$10.42B−$7.63B−$4.62B−$2.09B−$438.0M−$5.07B−$17.98B−$21.33B−$21.41B−$24.60B−$28.62B−$26.55B−$27.59B−$25.11B
Shareholders' equity$18.51B$20.89B$22.67B$23.94B$19.03B$19.06B$22.10B$25.78B$28.08B$29.88B$25.24B$12.50B$9.67B$9.41B$6.70B$3.66B$6.23B$5.88B$8.66B
Total liabilities and equity—$36.43B$39.63B$43.49B$48.87B$54.30B$66.13B$69.01B$71.45B$77.63B$79.95B$66.42B$59.71B$62.95B$61.16B$65.12B$97.15B$91.84B$90.59B
Total debt—$5.26B$10.60B$13.36B$21.43B$26.53B$32.13B$30.71B$31.43B$34.60B$35.34B$33.93B$30.43B$33.45B$33.98B$39.64B$65.42B$60.88B$55.44B
Net debt—−$4.29B−$2.84B−$4.06B$787.0M$2.47B$12.73B$3.69B$47.00M−$3.49B−$6.34B$4.63B$21.52B$22.80B$25.94B$30.34B$54.48B$48.91B$46.31B
Net working capital—$8.56B$12.18B$13.27B$14.89B$19.76B$15.62B$23.97B$25.71B$31.57B$36.66B$17.18B−$432.0M$3.23B−$788.0M−$1.13B$996.0M−$6.04B−$5.56B
Shares outstanding · period end—1.0B995M932M796M756M755M760M754M738M722M630M591M578M558M534M535M537M539M

Quarterly

Amgen balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$10.94B$9.71B$9.30B$9.01B$11.97B$8.81B$8.03B$9.45B$9.13B$12.04B$13.99B$13.19B
Short-term investments$0.00———————————
Cash and short-term investments$10.94B$9.71B$9.30B$9.01B$11.97B$8.81B$8.03B$9.45B$9.13B$12.04B$13.99B$13.19B
Accounts receivable$7.27B$6.78B$6.93B$7.32B$6.78B$8.13B$8.70B$8.49B$9.57B$9.14B$10.23B$10.35B
Inventory$9.52B$8.72B$8.00B$7.36B$7.00B$6.73B$6.58B$6.35B$6.22B$6.19B$6.22B$6.39B
Current assets$30.33B$28.03B$27.21B$26.77B$29.03B$26.93B$26.73B$27.89B$29.06B$31.48B$34.96B$34.36B
Property, plant and equipment$5.94B$6.00B$6.10B$6.16B$6.54B$6.68B$6.86B$7.22B$7.91B$8.22B$8.55B$8.88B
Goodwill$18.63B$18.57B$18.62B$18.66B$18.64B$18.64B$18.67B$18.68B$18.68B$18.67B$18.67B$18.66B
Acquired intangibles$32.64B$31.37B$30.17B$28.92B$27.70B$25.72B$24.61B$23.14B$22.28B$21.38B$20.49B$19.54B
Total assets$97.15B$92.98B$90.91B$90.88B$91.84B$89.37B$87.90B$90.14B$90.59B$92.50B$95.64B$96.05B
Accounts payable$1.59B$1.63B$2.27B$2.15B$1.91B$2.41B$3.01B$2.84B$2.37B$2.94B$2.87B$2.95B
Short-term borrowings$0.00———$0.00———$0.00———
Long-term debt · current portion$1.44B$3.96B$5.53B$3.54B$3.55B$3.37B$2.44B$2.15B$4.60B$5.44B$5.45B$2.40B
Current liabilities$18.39B$19.71B$21.52B$20.31B$23.10B$23.01B$20.48B$21.79B$25.49B$24.95B$25.50B$23.23B
Long-term debt · non-current$63.17B$60.06B$57.12B$56.85B$56.55B$54.01B$53.76B$52.43B$50.01B$51.89B$51.86B$51.61B
Operating lease liability$810.0M———$780.0M———$831.0M———
Total liabilities$90.92B$87.96B$84.98B$83.36B$85.96B$83.16B$80.47B$80.52B$81.93B$83.31B$83.95B$81.70B
Retained earnings−$26.55B−$27.87B−$27.12B−$25.53B−$27.59B−$27.14B−$25.71B−$23.80B−$25.11B−$24.65B−$22.27B−$19.81B
Shareholders' equity$6.23B$5.02B$5.92B$7.53B$5.88B$6.21B$7.43B$9.62B$8.66B$9.19B$11.69B$14.35B
Total liabilities and equity$97.15B$92.98B$90.91B$90.88B$91.84B$89.37B$87.90B$90.14B$90.59B$92.50B$95.64B$96.05B
Total debt$65.42B$64.02B$62.65B$60.40B$60.88B$57.38B$56.20B$54.59B$55.44B$57.32B$57.30B$54.01B
Net debt$54.48B$54.31B$53.34B$51.39B$48.91B$48.57B$48.18B$45.14B$46.31B$45.28B$43.31B$40.82B
Net working capital$996.0M−$1.39B−$3.61B−$2.56B−$6.04B−$4.89B−$1.77B−$3.35B−$5.56B−$5.52B−$4.53B−$2.06B
Shares outstanding · period end535M536M537M538M537M538M538M539M539M540M541M541M

The main figures as JSON and plain text. See data and methodology.

AMGN in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.